NasdaqCM - Nasdaq Real Time Price
USD
20/20 Biolabs, Inc. (AIDX)
0.2350
+0.0231
(+10.90%)
At close: November 2 at 4:00:02 PM EST
0.2257
-0.0093
(-3.96%)
After hours: November 2 at 4:06:54 PM EST
Key Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Jonathan Cohen
|
Founder, CEO, President & Director | 325.5k | -- | 1964 |
|
Dr. Jiming Zhou Ph.D.
|
Chief Operating Officer | 225.65k | -- | 1968 |
|
Dr. Michael Saul Lebowitz Ph.D.
|
Chief Scientific Officer | 89.6k | -- | 1969 |
|
Mr. Alan B. Bergman
|
Chief Financial Officer | -- | -- | 1969 |
|
Mr. David Lees
|
Director of Sales | -- | -- | -- |
|
Mr. Ronald R. Baker
|
Chief Business Officer | -- | -- | 1951 |
|
Marc Gordon
|
Controller | -- | -- | -- |
20/20 Biolabs, Inc.
15810 Gaither Road
Suite 235
Gaithersburg, MD 20877
United States
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 4
Description
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland.
Corporate Governance
20/20 Biolabs, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
